These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15908033)

  • 41. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins.
    Maretschek S; Greiner A; Kissel T
    J Control Release; 2008 Apr; 127(2):180-7. PubMed ID: 18314212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Doxorubicin-loaded (PEG)₃-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study.
    Ayen WY; Garkhal K; Kumar N
    Mol Pharm; 2011 Apr; 8(2):466-78. PubMed ID: 21288047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system.
    Lee BK; Yun YH; Choi JS; Choi YC; Kim JD; Cho YW
    Int J Pharm; 2012 May; 427(2):305-10. PubMed ID: 22366486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards developing surface eroding poly(alpha-hydroxy acids).
    Xu XJ; Sy JC; Prasad Shastri V
    Biomaterials; 2006 May; 27(15):3021-30. PubMed ID: 16455136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrafine medicated fibers electrospun from W/O emulsions.
    Xu X; Yang L; Xu X; Wang X; Chen X; Liang Q; Zeng J; Jing X
    J Control Release; 2005 Nov; 108(1):33-42. PubMed ID: 16165243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel--effect of additives.
    Shikanov A; Ezra A; Domb AJ
    J Control Release; 2005 Jun; 105(1-2):52-67. PubMed ID: 15955366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoporous materials modified with biodegradable polymers as models for drug delivery applications.
    Gruber MF; Schulte L; Ndoni S
    J Colloid Interface Sci; 2013 Apr; 395():58-63. PubMed ID: 23369801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications.
    Han J; Chen TX; Branford-White CJ; Zhu LM
    Int J Pharm; 2009 Dec; 382(1-2):215-21. PubMed ID: 19660536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nano-particles.
    Xiong XY; Tam KC; Gan LH
    J Control Release; 2005 Nov; 108(2-3):263-70. PubMed ID: 16199106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of UV Imaging in Formulation Development.
    Sun Y; Østergaard J
    Pharm Res; 2017 May; 34(5):929-940. PubMed ID: 27766463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug release behavior of electrospun twisted yarns as implantable medical devices.
    Maleki H; Gharehaghaji AA; Toliyat T; Dijkstra PJ
    Biofabrication; 2016 Sep; 8(3):035019. PubMed ID: 27634914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of amphiphilic chitosan-g-poly(ε-caprolactone) polymer additives on paclitaxel release from drug eluting implants.
    Shi W; Gu C; Jiang H; Zhang M; Lang M
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():502-9. PubMed ID: 25491857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic applications of electrospun nanofibers for drug delivery systems.
    Son YJ; Kim WJ; Yoo HS
    Arch Pharm Res; 2014 Jan; 37(1):69-78. PubMed ID: 24234913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling of drug release from biodegradable polymer blends.
    Lao LL; Venkatraman SS; Peppas NA
    Eur J Pharm Biopharm; 2008 Nov; 70(3):796-803. PubMed ID: 18577449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structured drug-eluting bioresorbable films: microstructure and release profile.
    Zilberman M; Shifrovitch Y; Aviv M; Hershkovitz M
    J Biomater Appl; 2009 Mar; 23(5):385-406. PubMed ID: 18632769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride.
    Vrignaud S; Anton N; Gayet P; Benoit JP; Saulnier P
    Eur J Pharm Biopharm; 2011 Sep; 79(1):197-204. PubMed ID: 21345371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers.
    Zeng J; Chen X; Liang Q; Xu X; Jing X
    Macromol Biosci; 2004 Dec; 4(12):1118-25. PubMed ID: 15586389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of acidic pH on PLGA microsphere degradation and release.
    Zolnik BS; Burgess DJ
    J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paclitaxel-eluting composite fibers: drug release and tensile mechanical properties.
    Zilberman M; Kraitzer A
    J Biomed Mater Res A; 2008 Feb; 84(2):313-23. PubMed ID: 17607755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.